Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.53 |
| ▸ | MEN1 | O00255 | 6/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | HTT | P42858 | 4/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11550849 | 0.84 | ALDH1A1 (0.61) | LMNAALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL11552111 | 0.80 | MEN1 (0.62) | LMNAALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL11551155 | 0.77 | ALDH1A1 (0.58) | LMNAALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL4679419 | 0.73 | HPGD (0.69) | LMNAALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL4682930 | 0.73 | LMNA (0.64) | LMNAALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL6626711 | 0.73 | LMNA (0.51) | LMNAALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL292487 | 0.72 | SMN1; SMN2 (0.62) | LMNAALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL3627085 | 0.72 | ALDH1A1 (0.55) | ALDH1A1MEN1KMT2AGAAALOX12 | |
| SCHEMBL6904494 | 0.72 | ALDH1A1 (0.58) | LMNAALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL4679156 | 0.71 | LMNA (0.62) | LMNAALDH1A1MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 876 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12391729-B2 | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | SPOGEN BIOTECH INC. (US) | 2025-08-19 | — | — | US | claimed |
| US-20240199709-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC (US) | 2024-06-20 | — | — | US | claimed |
| US-20210179672-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | GENISYS CREDIT UNION | 2021-06-17 | — | — | US | claimed |
| EP-2533633-B1 | FUNGICIDAL MIXTURES | LANXESS DISTRIB GMBH (DE) | 2017-02-01 | — | — | EP | claimed |
| WO-2016044655-A2 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC. (US) | 2016-03-24 | — | — | WO | claimed |
| US-20130195997-A1 | FUNGICIDAL MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2013-08-01 | — | — | US | claimed |
| EP-2533633-A2 | FUNGICIDAL MIXTURES | LANXESS Distribution GmbH (DE) | 2012-12-19 | — | — | EP | claimed |
| EP-2460408-A1 | Nematicidal compositions | deVGen N.V. (BE) | 2012-06-06 | — | — | EP | claimed |
| US-20110319435-A1 | FUNGICIDE MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2011-12-29 | — | — | US | claimed |
| WO-2011095492-A2 | FUNGICIDAL MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2011-08-11 | — | — | WO | claimed |
| EP-2315522-A2 | FORMATE-CONTAINING FUNGICIDE MIXTURES | LANXESS Distribution GmbH (DE) | 2011-05-04 | — | — | EP | claimed |
| EP-2153720-A1 | Fungicide mixtures comprising formate | LANXESS Distribution GmbH (DE) | 2010-02-17 | — | — | EP | claimed |
| WO-2010015635-A2 | FUNGICIDE MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2010-02-11 | — | — | WO | claimed |
| US-4146646-A | BIS-AMIDE FUNGICIDAL COMPOUNDS | FISONS LIMITED (GB) | 1979-03-27 | — | — | US | claimed |
| US-12630484-B2 | Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes | SPOGEN BIOTECH INC. (US) | 2026-05-19 | — | — | US | disclosed |
| US-12599141-B2 | Rod-shaped plant viral nanoparticles or virus-like particles for agricultural applications | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-04-14 | — | — | US | disclosed |
| US-12599649-B2 | Bioactive polypeptides for improvements in plant protection, growth and productivity | SPOGEN BIOTECH INC. (US) | 2026-04-14 | — | — | US | disclosed |
| WO-1997047620-A1 | N-SULFONYLIMIDAZOLES USED AS FUNGICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-12-18 | — | — | WO | disclosed |
| WO-1997008135-A1 | ACYLAMINOSALICYLIC ACID AMIDES AND THEIR USES AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-03-06 | — | — | WO | disclosed |
| US-4146646-A | BIS-AMIDE FUNGICIDAL COMPOUNDS | FISONS LIMITED (GB) | 1979-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630484-B2 | Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes | ADA, RNGTT, GNPDA1 | LMNA 3510/4885ALDH1A1 2323/4885MEN1 3413/4885 |
| US-12599649-B2 | Bioactive polypeptides for improvements in plant protection, growth and productivity | MAX, VIP, MRTO4 | LMNA 1747/4885ALDH1A1 4854/4885MEN1 3270/4885 |
| US-12599141-B2 | Rod-shaped plant viral nanoparticles or virus-like particles for agricultural applications | PRNP, PCNP, VIM | LMNA 273/4885ALDH1A1 3642/4885MEN1 964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.